Pictor and Rako Science bring improved access to COVID-19 antibody testing for New Zealand with technology from Tasso

AUCKLAND, New Zealand--(BUSINESS WIRE)--Pictor, a global leader in immunodiagnostics, today announced that its PictArray™ SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test will soon be available in New Zealand. Rako Science will utilize its national network by collecting blood samples with a device from Tasso, Inc., and undertake testing for COVID-19 antibodies. Pictor’s COVID-19 antibody test is the first of its kind The PictArray™ SARS-CoV-2 assay is the first test of its